Clincosm LogoSign in Get a demo

Graft vs Host Disease

Showing 26 - 50 of 150
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

GVHD Trial in United States (Belumosudil (KD025))

Completed
  • Graft vs Host Disease
  • Belumosudil (KD025)
  • Duarte, California
  • +6 more
May 27, 2022

Cutaneous T-Cell Lymphoma, Graft Vs Host Disease, Graft Rejection Trial in Besançon (Samples collection)

Recruiting
  • Cutaneous T-Cell Lymphoma
  • +2 more
  • Samples collection
  • Besançon, France
    Centre Hospitalier Universitaire de Besançon
May 31, 2022

Lymphoma, B-Cell, Lymphoma, Non-Hodgkin, Leukemia, B-cell Trial in Worldwide (Ibrutinib)

Enrolling by invitation
  • Lymphoma, B-Cell
  • +4 more
  • Burbank, California
  • +90 more
Mar 31, 2022

Graft Vs Host Disease Trial in Chapel Hill (Fluorothymidine (FLT))

Active, not recruiting
  • Graft Vs Host Disease
  • Fluorothymidine (FLT)
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center
Mar 21, 2022

Graft-versus-host-disease, Graft Vs Host Disease Trial in Saint Louis (Baricitinib)

Recruiting
  • Graft-versus-host-disease
  • Graft Vs Host Disease
  • Saint Louis, Missouri
    Washington University School of Medicine
Mar 4, 2022

Chronic GVHD Response Measures Validation

Active, not recruiting
  • Graft vs Host Disease
    • Seattle, Washington
      Fred Hutchinson Cancer Research Center
    Feb 28, 2022

    Graft Vs Host Disease Trial in Toronto (Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP),

    Recruiting
    • Graft Vs Host Disease
    • Drug or biologic - anti-thymocyte globulin (ATG), extracorporeal photopheresis (ECP), mTOR inhibitors (everolimus or sirolimus), vedolizumab, ruxolitinib.
    • Decidual Stromal Cells
    • Toronto, Ontario, Canada
      Princess Margaret Cancer Centre
    Feb 3, 2022

    GVHD Trial run by the NHLBI (Topical Dexamethasone, Placebo)

    Completed
    Has Results
    • Graft vs Host Disease
    • Topical Dexamethasone
    • Placebo
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    Jan 20, 2022

    Graft Vs Host Disease Trial in United States (PRO 140)

    Terminated
    • Graft Vs Host Disease
    • PRO 140
    • Miami, Florida
    • +7 more
    Jan 13, 2022

    Graft Vs Host Disease Trial in Boston (DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use, Regular

    Withdrawn
    • Graft Vs Host Disease
    • DEXTENZA (dexamethasone ophthalmic insert) 0.4 mg, for intracanalicular use
    • Regular dissolvable intracanalicular plug
    • Boston, Massachusetts
      Mass Eye and Ear
    Dec 14, 2021

    GVHD Trial in Minneapolis (Pregnyl®)

    Active, not recruiting
    • Graft vs Host Disease
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    Jan 3, 2022

    GVHD Trial in Japan (Ibrutinib)

    Completed
    • Graft vs Host Disease
    • Anjo-shi, Japan
    • +14 more
    Dec 30, 2021

    Graft Vs Host Disease, Haematological Malignancy, Cancer Trial in Hong Kong

    Recruiting
    • Graft Vs Host Disease
    • +2 more
      • Hong Kong, Hong Kong
        Department of Ophthalmology, LKS Faculty of Medicine, The Univer
      Dec 9, 2021

      Evaluation of GvHD Damage on Medullary Mesenchymal Stem Cells

      Recruiting
      • Graft Vs Host Disease
      • no intervention
      • Torino, Italy
        AOU Città della Salute e della Scienza di Torino
      Dec 7, 2021

      Hematologic Diseases, Acute Leukemia in Remission, Chronic Myelogenous Leukemia - Chronic Phase Trial in Ann Arbor (Vorinostat,

      Recruiting
      • Hematologic Diseases
      • +11 more
      • Ann Arbor, Michigan
        University of Michigan Health System
      Dec 2, 2021

      Graft Vs Host Disease Trial in Shenzhen (Umbilical Cord Mesenchymal Stem Cell Therapy)

      Recruiting
      • Graft Vs Host Disease
      • Umbilical Cord Mesenchymal Stem Cell Therapy
      • Shenzhen, Guangdong, China
        Li Yu
      Dec 4, 2021

      Graft Vs Host Disease Trial in Heidelberg (Supervised resistance training plus nutritional endorsement, Nutritional endorsement)

      Recruiting
      • Graft Vs Host Disease
      • Supervised resistance training plus nutritional endorsement
      • Nutritional endorsement
      • Heidelberg, Germany
        Heidelberg University Hospital
      Nov 8, 2021

      GVHD, Immune System Disorders Trial in United States (Etanercept, Mycophenolate Mofetil, Denileukin Diftitox)

      Completed
      Has Results
      • Graft vs Host Disease
      • Immune System Disorders
      • Duarte, California
      • +18 more
      Oct 19, 2021

      GVHD, AML, ALL Trial in Boston (FLUDARABINE, CYCLOPHOSPHAMIDE, TBI)

      Recruiting
      • GVHD
      • +15 more
      • Boston, Massachusetts
        Massachusetts General Hospital
      Sep 30, 2021

      GVHD Trial in Morgantown, Milwaukee (Atorvastatin calcium)

      Completed
      • Graft vs Host Disease
      • Atorvastatin calcium
      • Morgantown, West Virginia
      • +1 more
      Sep 9, 2021

      Graft Vs Host Disease, Hematopoietic Tumor Trial in Brazil (Methotrexate Injectable Solution)

      Recruiting
      • Graft Vs Host Disease
      • Hematopoietic Neoplasm
      • Methotrexate Injectable Solution
      • Rio De Janeiro, RJ, Brazil
      • +3 more
      Sep 10, 2021

      Stem Cell Transplant Complications, Graft Vs Host Disease, Coping Skills Trial in Boston (Horizon Program, Usual Care)

      Recruiting
      • Stem Cell Transplant Complications
      • +3 more
      • Horizon Program
      • Usual Care
      • Boston, Massachusetts
        Massachusetts General Hospital Cancer Center
      Aug 31, 2021

      Oral Mucositis Using Platelet Rich Fibrin TREATMENT OF ORAL

      Completed
      • Graft Vs Host Disease
      • +2 more
      • TREATMENT OF ORAL MUCOSITIS USING PLATELET-RICH-FIBRIN (PRF)
      • Taviano, Italy
        Francesco Gianfreda
      Aug 18, 2021

      Stem Cell Transplantation, GVHD Trial run by the CC (Budesonide, Fluconazole, Voriconazole)

      Terminated
      • Stem Cell Transplantation
      • Graft vs Host Disease
      • Bethesda, Maryland
        National Institutes of Health Clinical Center, 9000 Rockville Pi
      Mar 11, 2021

      Graft Vs Host Disease Trial in Beijing (UC-MSC, Anti-CD25 mAb)

      Not yet recruiting
      • Graft Vs Host Disease
      • Beijing, Beijing, China
        Peking University Insititute of Hematology, Peking University Pe
      Feb 1, 2021